• Mashup Score: 1

    Nature Communications – Raynaud’s phenomenon is a common vasospastic disorder, but the genetic origins of the condition are not well understood. Here, the authors find common genetic variants…

    Tweet Tweets with this article
    • Genetic study from UK Biobank: #Raynaud’s phenomenon and ⬆️α2A-adrenoreceptor signaling (ADRA2A,’ gene). Nice to see mechanistic research for rarer vascular disorders. #MedEd https://t.co/vCuO7nc7vG https://t.co/ihlZ40mFRS

  • Mashup Score: 0

    We spoke with Dr. Kate Bedrin, one of the authors of “Raynaud’s phenomenon associated with calcitonin gene-related peptide receptor antagonists case report” …

    Tweet Tweets with this article
    • 🗣️ New @ahsheadache @HeadacheJournal interview! We spoke with Dr. Kate Bedrin, one of the authors of: #Raynaud's phenomenon associated with #CGRP receptor antagonists case report 🎙️Interview link: https://t.co/8qCnTEfIWZ Manuscript can be accessed with the link below! ⬇️ https://t.co/XIi8CIg23W https://t.co/uxLPVca8io

  • Mashup Score: 5

    A 72-year-old man, recently diagnosed with squamous cell carcinoma of the skin with left parotid gland metastasis (status postparotidectomy and radiation), hypothyroidism, hypertension, and allergic rhinitis presented with puffy fingers and Raynaud phenomenon (RP). Medications included acetaminophen, oxycodone, lisinopril, loratadine, senna, and multivitamins.

    Tweet Tweets with this article
    • Great educational article & case on ➡️#Raynaud's ➡️#SystemicSclerosis ➡️#Scleroderma renal crisis 👉🏽https://t.co/0TV0aaZq1u via @MayoProceedings https://t.co/NDepe1rweC

  • Mashup Score: 1

    OnabotulinumtoxinA has been implemented as a treatment of intractable Raynaud phenomenon after failure with traditional treatments, such as calcium channel blockers, angiotensin receptor blockers, prostaglandins, endothelin receptor blockers, and phosphodiesterase 5 inhibitors.

    Tweet Tweets with this article
    • Here’s a patient with #Raynaud syndrome who also had a history of APS and SLE along with symptoms of polymyositis + scleroderma. https://t.co/uEEyOElc4X #CutisJournal

  • Mashup Score: 2

    OnabotulinumtoxinA has been implemented as a treatment of intractable Raynaud phenomenon after failure with traditional treatments, such as calcium channel blockers, angiotensin receptor blockers, prostaglandins, endothelin receptor blockers, and phosphodiesterase 5 inhibitors.

    Tweet Tweets with this article
    • Practice Points: #Raynaud phenomenon is a vascular disorder characterized by intermittent arteriolar vasospasm of the digits, often due to cold temperature or stress. Roughly 90% of RP cases are primarily idiopathic. https://t.co/ly9ti1Fyo6 https://t.co/0ESnQc1I0O